![Klaus Maleck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Klaus Maleck - Operating Partner
Klaus joined ArchiMed in 2020 as an Operating Partner.
He has over 25 years of experience in management consulting and corporate leadership in the Healthcare industry.
At ArchiMed, Klaus is particularly focused on the Biotech sector.
Klaus started his career at the Biotechnology and Genomics Center of Novartis Inc. He then joined McKinsey & Company as a Senior Consultant.
He co-founded and lead in his function as CFO BioGenerix AG, the biosimilar business of the ratiopharm group.
This was followed by Klaus assuming an executive role at Evotec AG, during which he led a major turn-around, including a Nasdaq listing and numerous corporate development activities.
Following this, he joined TETEC AG, a pioneer and market leader in cell therapy development and manufacturing, as CEO.
Klaus holds a PhD in Biochemistry from the Max-Planck Institute and an MBA.
Klaus is a German citizen and speaks fluent English.
| Società | Posizione | Inizio |
|---|---|---|
Tissue Engineering Technologies AG
 Tissue Engineering Technologies AG BiotechnologyHealth Technology Manufactures bacterial and virus vaccines, toxoids & analogous products | Corporate Officer/Principal | - |
ITM Solucin GmbH
 ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development services | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
ArchiMed SAS
 ArchiMed SAS Investment ManagersFinance ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments. | Investitore di Private Equity | 31/03/2023 |
European ScreeningPort GmbH | Presidente | - |
| EVOTEC SE | Direttore Finanziario/CFO | 13/08/2010 |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 8 |
|---|---|
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
University of Strasbourg
 University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European ScreeningPort GmbH | |
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Manufactures bacterial and virus vaccines, toxoids & analogous products | Health Technology |
Max Planck Institut für Pflanzenzüchtungsforschung
 Max Planck Institut für Pflanzenzüchtungsforschung Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität Educatis
 Universität Educatis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArchiMed SAS
ArchiMed SAS Investment ManagersFinance ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments. | Finance |
ITM Solucin GmbH
ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development services | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
